chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her sister currently testing positive for COVID, despite getting the vaccine; her sister currently testing positive for COVID, despite getting the vaccine; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (sister) reported for a female patient of an unspecified age received first dose of bnt162b2 (BNT162B2, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE for covid-19 immunization.  The patient medical history and concomitant medications were not reported. The patient experienced contracted covid after getting the first dose of vaccine 5 days prior. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on an unspecified date. Scheduled for 2nd dose of COVID Vaccine on 15May, but wanted to know if they should keep the appointment, with her sister currently testing positive for COVID, despite getting the vaccine. The reporter considered events as non-serious. The outcome of the events was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained .
I experienced a fever of 101 to 102, chills, nausea, headache, and body aches that continued until 02/03/2022 before improving. I woke up with facial flushing, severe headache and had another telehealth visit on 02/04/2022, and my symptoms did not abate until 02/07/2022. I was diagnosed with non-intractable headache, facial flushing, body aches and nausea on my two visits. My symptoms fully resolved and have not returned. On 06/25/2022 I developed a rash on my neck, chest, face, groin, and inside of my fingers. I was prescribed Prednisone on 06/27/2022 and they resolved on 07/04/2022. The rash returned on 07/30/3033 and I began Prednisone again 08/05/2022, but it has not resolved yet.
COVID-19; COVID-19; This is a spontaneous report from a non-contactable HCP. A female patient of an unspecified age received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via an unspecified route of administration on an unspecified date as dose number unknown single for COVID-19 immunization. Medical history was not reported. Concomitant medications included rituximab (RITUXAN). It was reported that adverse reaction concerning a patient who used one of your products, Pfizer COVID-19 vaccine. On unknown date. it was reported that patient experienced: COVID-19. The outcome of the reported event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Based on the information in the case report, A possible causal relationship between Covid-19 and suspect product BNT162B2 cannot be excluded.
August 20th I noticed major bruises on my right leg, right arm, left arm. Bruising a lot easier and bruises are lasting a lot longer. Bruises are circular and in small clustets. Pain near the inside of my left elbow (similar to the aching feeling after getting blood drawn) last days at a time and goes on and off with how badly it hurts.
Vaccine error. The patient received Dose 1 Moderna 1/28/2021 (lot 004M20A) and recieved the second dose of Pfizer in error. The dose should have been Moderna. The event occurred at a large vaccine site administered jointly bt.  This event is being reported as a vaccine error to assist in data collection and process improvement. CDC recommendations are that no further action is needed at this time.
Feeling weird; Tightness in her chest; Like when you smoke a pack of cigarettes and that kind of soreness.; This spontaneous case was reported by a patient and describes the occurrence of FEELING ABNORMAL (Feeling weird), CHEST DISCOMFORT (Tightness in her chest) and MYALGIA (Like when you smoke a pack of cigarettes and that kind of soreness.) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Sep-2021, the patient experienced FEELING ABNORMAL (Feeling weird), CHEST DISCOMFORT (Tightness in her chest) and MYALGIA (Like when you smoke a pack of cigarettes and that kind of soreness.). At the time of the report, FEELING ABNORMAL (Feeling weird), CHEST DISCOMFORT (Tightness in her chest) and MYALGIA (Like when you smoke a pack of cigarettes and that kind of soreness.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant use were reported No Treatment were reported
Right ankle started to swell,Still swelling, getting bigger, bigger as size of grape fruit; Joint pain in right clavicle; arm was sore at injection site; This spontaneous case was reported by a health care professional and describes the occurrence of OEDEMA PERIPHERAL (Right ankle started to swell,Still swelling, getting bigger, bigger as size of grape fruit), ARTHRALGIA (Joint pain in right clavicle) and INJECTION SITE PAIN (arm was sore at injection site) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     The patient's past medical history included Psoriasis and Hepatitis C.    On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, the patient experienced INJECTION SITE PAIN (arm was sore at injection site). On 18-Apr-2021, the patient experienced ARTHRALGIA (Joint pain in right clavicle). On 19-Apr-2021, the patient experienced OEDEMA PERIPHERAL (Right ankle started to swell,Still swelling, getting bigger, bigger as size of grape fruit). At the time of the report, OEDEMA PERIPHERAL (Right ankle started to swell,Still swelling, getting bigger, bigger as size of grape fruit), ARTHRALGIA (Joint pain in right clavicle) and INJECTION SITE PAIN (arm was sore at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   no treatment medication and concomitant medication provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: significant follow up-contact information updated
Onset of sharp, shooting chest pains at anterior left upper chest and anterior right lower chest as well as mild wheezing within 1 hour of vaccine administration on 2/17/21. This continued daily until an episode of hemoptysis on 5/11/21, for which she was admitted for inpatient management.
Patient was given PNEUMOVAX vaccination on 8/12/2014 but the vaccination expiration was on 8/10/2014. No adverse event occurred.
Patient developed abdominal pain and fever a few days after his flu vaccine.  He was ultimately diagnosed with MIS-C.
This spontaneous report was received from a nurse refers to 4 patients of unknown age and gender. on an unknown date the patients were vaccinated with (Oka/Merck) VARIVAX, 0.5 ml, subcutaneous. No other concomitant therapies reported. On an unknown date the nurse reported that 4 patients each received a dose of (Oka/Merck) VARIVAX that had been exposed to temperatures warmer than the recommended temperatures in the prescribing information (18.1F 22.3F during daily defrost cycles). No adverse effect reported. The outcome of the event was unknown. The causality of the events was unspecified. No PQC involved. Additional information has been requested.
sluggish, 103 fever. moved into neck, took 2 Tylenols at 7
25 years old in otherwise good health. Presented to observation area and within 5 minutes reported feeling lightheaded to staff member, then almost immediately had a syncopal episode with +LOC. He was caught by staff member and noted to have seizure like jerky movements for about 20 seconds. He regained consciousness and was A&O x 3. He was not post ictal. Brought to 1st aid bay. BP initially 87/47, HR 66. Offered water. BP recheck 104/58, 76. Lungs clear. HRR. No chest tightness, chest pain or SOB. Symptoms completely resolved. He reports episode like this in 7th grade which he think was secondary to anxiety. EMS offered to take to ED for further evaluation but he declined. His father took him home.
Side effects included fever of 100.4. , body aches,  vomiting, extreme chills, headache, diarrhea, lethargy, weakness, one bout of Atrill Fib. Side effects lasted about 3 days...leaving me tired and shaky but feeling stronger.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 54-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), in May2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 51 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "GERD" (unspecified if ongoing); "Anxiety" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Sep2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, COVID-19: the patient received treatment with Paxlovid from 03Sep2023 to 07Sep2023.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
04Jan91 pt vax w/ MMR; 14Jan91 devel muscle aches + temp 102.5F for 4 days. 18Jan91 devel maculo-papular rash, partly confluent, on upper torso, neck, head, upper arms, + behind ears + occipital paresthesia. Tx w/ non-specific prescription.
Two weeks after receiving the booster vaccine I developed hives.  They would pop up, be red, bumpy and itchy for about a half hour, then go away.  I went on steroids for 5 days, which made it good, but as soon as I came off of them, the hives were back.  I would have a flair up in the morning, be good at work all day, then they would come back out between 5:30 and 7:00 in the evening.  I was taking Benadryl to get through the night for a few weeks, then I went to my primary doctor on 12-14-21.  She advised me to switch to Zyrtec D, which has been amazing, for one week then come off of it, that would be today.  I have had some red splotches develop while on the Zyrtec, but it has not been itchy.  The reason I believe it may be from the booster shot, is because 3 other people in my office who received the booster on the same day are going through the same symptoms.
Suspected vaccination failure; Still got shingles / just getting back to normal; The sores dried up / just getting back to normal; But still had residual nerve pain for a while after / just getting back to normal; This case was reported by a consumer via (Facebook) interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant), shingles, skin ulcer and nerve pain. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles and skin ulcer were recovering/resolving and the outcome of the nerve pain was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure, shingles, skin ulcer and nerve pain to be related to Shingles vaccine.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient had shot still got shingles. The sores dried up but still had residual nerve pain for a while after. The patient was getting back to normal. The reporter stated that vaccine might make your case lighter but it won't prevent it. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization for shingles, time to onset for event and laboratory confirmation for shingles were not provided.
Baby born stillborn to vaccinated mother. Was pregnant at start of 2nd trimester when vaccine was received. Pregnancy seemed to progress uncomplicated. Due date was 10/8/21. Baby was moving around a s had a heartbeat on 10/8/21. A scheduled C-section was set for 10/15/21. Upon arrival to hospital for scheduled C-section baby was found to have no heartbeat and was born stillborn. Nothing visibly wrong with baby girl (e.g. no cord wrapped around neck, no obvious trauma or deformities not viable to life, etc.).
Had hot circle on arm; Had itchy circle on arm; Red circle on arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Had hot circle on arm), VACCINATION SITE PRURITUS (Had itchy circle on arm) and VACCINATION SITE ERYTHEMA (Red circle on arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced VACCINATION SITE WARMTH (Had hot circle on arm), VACCINATION SITE PRURITUS (Had itchy circle on arm) and VACCINATION SITE ERYTHEMA (Red circle on arm). At the time of the report, VACCINATION SITE WARMTH (Had hot circle on arm), VACCINATION SITE PRURITUS (Had itchy circle on arm) and VACCINATION SITE ERYTHEMA (Red circle on arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
A non-serious report of runny nose and fever was received from a consumer concerning a five-year-old female. No medical history or concomitant medications were reported. The patient received FLUMIST on 13-Oct-2008. On 15-Oct-2008, two days after receiving FLUMIST, the patient and her sibling developed runny nose; the following day on 16-Oct-2008, the patient developed a fever. The event of runny nose and fever resolved on 17-Oct-2008.
Noticed at bedtime that my face had swelled up and was slightly blotchy. There were no other symptoms beside this. I took a benadryl and used topical hydrocortisone in case it was a rash. The swelling was 90% resolved by the next morning and completely gone by the next evening. There were no other symptoms.
product she used may have been recalled / Possibly received recalled vaccine; product she used may have been recalled / Possibly received recalled vaccine; product she used may have been recalled / Possibly received recalled vaccine; product she used may have been recalled / Possibly received recalled vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of recalled drug administered in a 68-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix and the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced recalled drug administered (Verbatim: product she used may have been recalled / Possibly received recalled vaccine), recalled drug administered (Verbatim: product she used may have been recalled / Possibly received recalled vaccine), product dispensing error (Verbatim: product she used may have been recalled / Possibly received recalled vaccine) and product dispensing error (Verbatim: product she used may have been recalled / Possibly received recalled vaccine). The outcome of the recalled drug administered, recalled drug administered, product dispensing error and product dispensing error were unknown.   Additional Information: GSK Receipt Date: 06-JUL-2023 The patient self-reported this case. The reporter asked if her Flovent was on recall. No recall found in content. The reporter stated she received a call stating a GSK product she used might had been recalled. She did receive 2 doses of Shingrix around 6 months ago from reporting (did not know lot number), which led to recalled drug administered and product dispensing error. The reporter consented to follow up.
scar; This case was reported by a nurse via interactive digital media and described the occurrence of scar in a patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles in 2007).   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced scar. On an unknown date, the outcome of the scar was unknown.   It was unknown if the reporter considered the scar to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported. The patient had the two shots in 2019.  Had a scar on neck from them.  The patient I can't wear a backless because of my scar.  It was reported they do affect your life sometimes, by the way the patient was a retired nurse.
Vaccine administered after more than 1 temperature excursion; Vaccine administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021 at 3:21 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 06-Jan-2021 at 3:21 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Vaccine administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (Vaccine administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 78.27.  Concomitant products were not provided.  On 06-Jan-2021, Excursion time was 03 PM, temperature was 35, total doses given for the day was 32, condition of vaccine prior to administration was not frozen, vaccine was moved to fridge on 05-Jan-2021, vial was moved to clinic on 06-Jan-2021. 3 vials were sent to clinic. Vaccine BUD date was 27-Jan-2021.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  After administration, the vial was returned to the freezer/refrigerator, or maintained at room temperature.  It was reported that the patient was administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 and half hour approximately, when the temperature data logger registered 34 or 35 degree F.  Treatment medications were not reported.
Heavier spotting after the second administered dose while still on the pill; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 41 year old non pregnant female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Left on 29May2021 (Batch/Lot Number: EW0187) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included ethinylestradiol, ferrous fumarate, norethisterone acetate (JUNEL FE) taken for an unspecified indication, start and stop date were not reported. The patient previously took oxycodone, albuterol. The patient experienced Light spotting for a week after the first dose administration while still on the contraceptive pill and heavier spotting after the second administered dose while still on the pill for intermenstrual bleeding on 30May2021 with outcome of recovered.    Follow-up (23Aug2021): Follow-up attempts are completed. No further information is expected.
Pain in right ventrolateral for over nine months. Felt like someone was consistently frogging me. In the beginning I could not lift my arm.
Tennis ball size red welt in the arm where I was injected.   Sore, painful , stiffness in the arm.    Small red marks on the arms    Chills, muscle aches, joint pain, low fever, nausea for approximately 36 hours.     Symptoms subsided on Saturday except for the large red welt on my arm which itches and is very soar to touch
After my first dose vaccine,  was in bed for 24 hours due to bad headaches and nausea. I have history of prostate cancer. I called my doctor due to my symptoms of not feeling well. At the time of vaccine, I was also on immunotherapy trial for prostate cancer. My doctor states it could been an interaction with the medication I am receiving for my immunotherapy which was Keytruda in combination with the Moderna vaccine. I took Ibuprofen for pain and about 24 hours later I began to feel better.   I also had my second vaccine on 02-10-2021, lot#: 02520A, left arm, dose:2. I only had chills, six hours after my vaccine and no other symptoms.
Nausea w/in hr p/shot; stayed @ school until 1130 & couldn't stand it; then joint in the arm became very painful; The site of inject became hard to the touch; no fever & the joint ached x 1 wk;
Almost immediately the pain hit me on my right shoulder, I felt like I had a horrible flu for about 2 days with headaches, body pains, I self medicated at home with Tylenol, tramadol and Norco and after 4 or 5 days I felt like I was ok. I still feel soreness, depending on how I move my arm. but it is not bad that I need to take anything. But the pain soon after the vaccine was excruciating.
I had a very sore arm and malaise with a temperature as high as 101.5-101.8 the day after. The next two days just moderately sore arm. On Tuesday January 19 I developed a cough. By next day I was very ill (fatigue, aches and pains, burning eyes, fever up to 103, headache, flu-like). Today I developed hives.
Information was received from a pharmacist concerning a 61 year old female with no pertinent medical history, no known allergies, and no concomitant medications. On 12-JAN-2016, the patient received ZOSTAVAX for vaccination (lot number, expiration date, dosage, and route of administration not provided) which was reconstituted with diluent (lot number not provided). On 28-APR-2017, the patient reported that she has been experiencing unspecified pain for the last year since the ZOSTAVAX vaccination. It was also reported that "she now has shingles."  The outcome of the events was reported as not recovered. No further information reported. Additional information has been requested.
Starting 03/20/2022, I developed a sore throat and a bit of congestion. I woke up the next morning feeling the same and I took an at home test which was positive. I cancelled travel plans and quarantined for 5 days. I didn't develop too severe of symptoms but I had severe congestion, minor cough and the worse symptom was a sore on my tongue that lasted for about 10 days. It made it hard to talk or eat. After about 5 days, all the symptoms but the sore on the tongue were pretty much resolved.